DJIA 17,120.70 68.97 0.40%
NASDAQ 4,460.57 35.87 0.81%
S&P 500 1,985.18 11.55 0.59%
market minute promo

Celgene (NASDAQ: CELG)

86.53 1.22 (1.43%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $86.51 1.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $86.18
Previous Close $85.31
Daily Range $85.87 - $87.12
52-Week Range $65.76 - $90.50
Market Cap $69.3B
P/E Ratio 54.34
Dividend (Yield) $0.00 (0.0%)
Volume 1,070,733
Average Daily Volume 4,882,975
Current FY EPS $3.18

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

Can Celgene Deliver in 2014?

Celgene (NASDAQ: CELG) had a strong 2013, but 2014 is not quite going to plan. Can it turn things around?

Biogen Shares Rebound As Street Has A Change Of Heart

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?

Top Biotech Earnings Previews for the Week Ahead

3 Stocks Reiterated As A Buy: COP, CELG, AXP

Biotech Enters Reporting Season With Large Caps Central To Sector Performance

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Cramer: The Tell of When to Sell

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Anal

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog

Today's Market: Tech, Biotech And Social Media Stocks In The News

UPDATE: Morgan Stanley Reiterates On Celgene As EU Patents Risk May Be Underappreciated

See More CELG News...

CELG's Top Competitors

CELG $86.53 (1.43%)
Current stock: CELG
AMGN $120.63 (1.34%)
Current stock: AMGN
GILD $88.74 (-0.14%)
Current stock: GILD
$0.00 (0.00%)
Current stock: